Drug profile · INN
sulfadiazine
SULFADIAZINE
sulfadiazine (SULFADIAZINE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — sulfadiazine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
sulfadiazine (SULFADIAZINE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial dihydropteroate synthase inhibitor
Primary target: Dihydropteroate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sulfadiazine?
sulfadiazine (SULFADIAZINE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sulfadiazine?
SULFADIAZINE is a marketed brand name for sulfadiazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfadiazine?
sulfadiazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.